701. Comparison of MIC Results for Gepotidacin by Agar Dilution and Broth Microdilution Methods

BACKGROUND: Gepotidacin (GSK2140944) is a novel triazaacenaphthylene bacterial type II topoisomerase inhibitor in clinical development for the treatment of gonorrhea and uncomplicated UTI (acute cystitis). Gepotidacin selectively inhibits bacterial DNA gyrase and topoisomerase IV by a unique mechani...

Descripción completa

Detalles Bibliográficos
Autores principales: Arends, S J Ryan, Canino, Michele A, Roth, Brieanna M, Rhomberg, Paul R, Flamm, Robert K, Scangarella-Oman, Nicole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811067/
http://dx.doi.org/10.1093/ofid/ofz360.769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811067/
http://dx.doi.org/10.1093/ofid/ofz360.769

Ejemplares similares